Compare ACHV & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHV | ESRT |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.5M | 834.5M |
| IPO Year | 2018 | 2012 |
| Metric | ACHV | ESRT |
|---|---|---|
| Price | $7.00 | $4.84 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 6 |
| Target Price | ★ $14.15 | $5.40 |
| AVG Volume (30 Days) | 1.3M | ★ 4.8M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $768,270,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.05 |
| 52 Week Low | $2.62 | $3.93 |
| 52 Week High | $8.64 | $8.04 |
| Indicator | ACHV | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 70.39 |
| Support Level | $6.92 | $3.95 |
| Resistance Level | $7.11 | $5.85 |
| Average True Range (ATR) | 0.38 | 0.14 |
| MACD | -0.07 | 0.10 |
| Stochastic Oscillator | 13.10 | 94.77 |
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.